Common bladder drug may ease kidney stone surgery

NCT ID NCT07566416

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 131 people having surgery for kidney stones. Some were already taking mirabegron for overactive bladder, which relaxes the ureter. Researchers wanted to see if this helped surgeons insert a tube more easily and caused less injury. The idea is that a relaxed ureter might make the procedure smoother.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
mirabegron
What this could lead to
If it works, this could make kidney stone surgery easier and safer by relaxing the ureter, potentially reducing complications.
What could go wrong
This is a small, retrospective study, not a controlled trial. Results may not apply to everyone, and mirabegron's effect on surgery success is still uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KIDNEY STONE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Kidney Calculi nephrolithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ankara Training and Research Hospital

    Ankara, Altındağ, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.